title: Ipilimumab for advanced melanoma: let's not throw caution to the winds.
authors.affiliation: Department of Surgery, Emory University School of Medicine. Atlanta, Georgia, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Lowe
authors.forename: Keith A
authors.initials: KA
authors.lastname: Delman
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015703:Antigens, CD; D060908:CTLA-4 Antigen; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007167:Immunotherapy; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab